Pfizer has taken a $1.2 billion hit after reassessing the prospects of two antibody-drug conjugates (ADC) it picked up in the ...
As norda gears up for the release of its next-generation 005 later this year, the brand is keeping the pipeline warm with new ...
The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback